Changing market conditions are catapulting pharmacists into the pivotal role of patrolling a third class of drugs.
FDA Clears DASH SARS-CoV-2, Flu A/B Combination Test
Using the DASH Rapid PCR System, providers can yield test results in under 1 minute of hands-on time.
Episode 8: Stay in Sync with Innovations in Medication Decision Support
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
FDA Updates Veozah Label With Boxed Warning for Rare But Serious Liver Injury
The patient’s symptoms gradually resolved after discontinuing fezolinetant therapy.
Tapinarof Cream 1% Approved by FDA to Treat Atopic Dermatitis in Adults, Children 2 Years and Older
Vtama from Organon was previously approved in May 2022 to treat plaque psoriasis in adults.
FDA Roundup: ATX101 Gains Breakthrough Therapy Designation, Stelara Biosimilar Approval
Catch up on important FDA news from the week of December 2.
FDA Approves Acoramidis for ATTR-CM
This approval marks the availability of the first near-complete stabilizer of transthyretin.